As one of the nation’s leading academic medical centers, UT Southwestern offers a broad array of clinical trials aimed at improving the outcomes for patients at various stages of pancreatic cancer.
Patients who qualify and choose to participate in one of our clinical trials might receive promising new therapies months or even years before they are available to the public, providing hope for better outcomes and improving care for all patients.
Patients interested in being considered for a pancreatic cancer clinical trial should speak with their UT Southwestern physician or the contact associated with a specific trial.